<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39447661</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-1208</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>22</Day></PubDate></JournalIssue><Title>Microbial pathogenesis</Title><ISOAbbreviation>Microb Pathog</ISOAbbreviation></Journal><ArticleTitle>Emergence and spread of resistant and biofilm-forming Acinetobacter baumannii in critically ill COVID-19 patients.</ArticleTitle><Pagination><StartPage>107078</StartPage><MedlinePgn>107078</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.micpath.2024.107078</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0882-4010(24)00545-X</ELocationID><Abstract><AbstractText>The COVID-19 pandemic has raised concerns beyond the viral infection itself. Bacterial co-infections, particularly those involving Acinetobacter baumannii, have become a significant worry in critically ill COVID-19 patients. A. baumannii is an opportunistic pathogen that can cause nosocomial infections, especially in patients with compromised immune systems. This study investigated 36 A. baumannii isolates obtained from COVID-19 patients during a concurrent outbreak. The isolates were collected over two years through routine medical requests sent to the Clinical Microbiology laboratory. Identification of the strains was confirmed through biochemical tests, the Phoenix BD® Automated Microbiology System, and MALDI-TOF Mass Spectrometry. The study assessed the antimicrobial sensitivity of the isolates, with a specific focus on resistance to the beta-lactam group as well as aminoglycosides. The presence of specific antibiotic resistance genes (bla<sub>OXA-23</sub>, <sub>-24</sub>, <sub>-51</sub> and <sub>-58</sub>, bla<sub>KPC</sub>, bla<sub>SHV</sub>, bla<sub>IMP</sub>, bla<sub>VIM</sub>, aac(6')-Ib, ant(3'')-Ia, and aph(3')-Ia) was investigated using PCR and Sanger DNA sequencing. Biofilm-forming capabilities of the isolates were also evaluated. The findings revealed diverse resistance profiles, with a high prevalence of resistant strains, including resistance to carbapenems. Genetic analysis suggested potential clonal spread of certain strains within the hospital setting. Moreover, a significant proportion of the isolates demonstrated strong biofilm-forming abilities, which can enhance persistence and antibiotic resistance. In conclusion, this study highlights the need for vigilant monitoring and targeted interventions to address bacterial co-infections in COVID-19 patients. The diversity in resistance patterns, potential clonal spread, and robust biofilm-forming abilities among A. baumannii isolates underscore the importance of addressing this issue to better manage and treat critically ill COVID-19 patients.</AbstractText><CopyrightInformation>Copyright © 2024. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>Rafael Thiago Pereira da</ForeName><Initials>RTPD</Initials><AffiliationInfo><Affiliation>Federal University of Pernambuco - UFPE, Department of Pharmacology, Recife, PE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rocha</LastName><ForeName>Igor Vasconcelos</ForeName><Initials>IV</Initials><AffiliationInfo><Affiliation>Aggeu Magalhães Institute, Oswaldo Cruz Foundation - FIOCRUZ-PE, Department of Microbiology, Recife, PE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dantas</LastName><ForeName>Tainara Fernandes</ForeName><Initials>TF</Initials><AffiliationInfo><Affiliation>Federal University of Pernambuco - UFPE, Department of Pharmacology, Recife, PE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>Jaqueline Dos Santos</ForeName><Initials>JDS</Initials><AffiliationInfo><Affiliation>Federal University of Pernambuco - UFPE, Department of Pharmacology, Recife, PE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costa Júnior</LastName><ForeName>Sérgio Dias da</ForeName><Initials>SDD</Initials><AffiliationInfo><Affiliation>Federal University of Paraíba - UFPB, Health Sciences Center, Department of Physiology and Pathology, João Pessoa, PB, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luz</LastName><ForeName>Ana Carolina de Oliveira</ForeName><Initials>ACO</Initials><AffiliationInfo><Affiliation>Aggeu Magalhães Institute, Oswaldo Cruz Foundation - FIOCRUZ-PE, Department of Microbiology, Recife, PE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreno</LastName><ForeName>Marcelo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Federal University of Paraíba - UFPB, Health Sciences Center, Department of Physiology and Pathology, João Pessoa, PB, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leal-Balbino</LastName><ForeName>Tereza Cristina</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>Aggeu Magalhães Institute, Oswaldo Cruz Foundation - FIOCRUZ-PE, Department of Microbiology, Recife, PE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Araújo Lima</LastName><ForeName>Ana Vitória</ForeName><Initials>AV</Initials><AffiliationInfo><Affiliation>Federal University of Pernambuco - UFPE, Department of Pharmacology, Recife, PE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>Evandro G da</ForeName><Initials>EGD</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Regional University of Cariri - URCA, Department of Biological Chemistry, Crato, CE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coutinho</LastName><ForeName>Henrique Douglas Melo</ForeName><Initials>HDM</Initials><AffiliationInfo><Affiliation>Regional University of Cariri - URCA, Department of Biological Chemistry, Crato, CE, Brazil. Electronic address: hdmcoutinho@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveira</LastName><ForeName>Maria Betânia Melo de</ForeName><Initials>MBM</Initials><AffiliationInfo><Affiliation>Federal University of Pernambuco - UFPE, Department of Pharmacology, Recife, PE, Brazil. Electronic address: maria.bmoliveira@ufpe.br.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Microb Pathog</MedlineTA><NlmUniqueID>8606191</NlmUniqueID><ISSNLinking>0882-4010</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Biofilm formation</Keyword><Keyword MajorTopicYN="N">Drug Resistance</Keyword><Keyword MajorTopicYN="N">Epidemiological surveillance</Keyword><Keyword MajorTopicYN="N">Gram negative</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest ☒The authors declare that they have no known competing financialinterestsor personal relationships that could have appeared to influence the work reported in this paper. ☐The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>0</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>0</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>19</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39447661</ArticleId><ArticleId IdType="doi">10.1016/j.micpath.2024.107078</ArticleId><ArticleId IdType="pii">S0882-4010(24)00545-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle>